Magellan Diagnostics LeadCare Ultra and LeadCare Plus test Kits. Product Usage: The LeadCare ...

FDA Device Recall #Z-2226-2017 — Class I — May 23, 2017

Recall Summary

Recall Number Z-2226-2017
Classification Class I — Serious risk
Date Initiated May 23, 2017
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Magellan Diagnostics, Inc.
Location North Billerica, MA
Product Type Devices
Quantity 6018 kits (total)= 5818 (US)and 200 (OUS)

Product Description

Magellan Diagnostics LeadCare Ultra and LeadCare Plus test Kits. Product Usage: The LeadCare Blood Lead Test Kit is for in vitro diagnostic use only. The Test Kit is for the quantitative measurement of lead in fresh whole blood. This product is for professional use only. Sensors and Treatment Reagent of the Test Kit are specific for lead only. Contents of this LeadCare Blood Lead Test Kit must only be used with a LeadCare Analyzer and Blood Lead Testing System.

Reason for Recall

Underestimates the lead concentration of venous blood samples when the sample is analyzed with the LeadCare systems

Distribution Pattern

Worldwide Distribution - US (Nationwide) Foreign: AUSTRALIA AUSTRIA BOLIVIA CANADA CHILE CHINA COLOMBIA DOMINICAN REPUB ENGLAND GERMANY INDIA UK ISRAEL ITALY JAPAN KOREA MALI MYANMAR SPAIN NEPAL NETHERLANDS NEW ZEALAND P.R. CHINA PANAMA US PERU PHILLIPINES POLAND PORTUGAL REP OF KOSOVO SOUTH AFRICA SRI LANKA USA SWEDEN SWITZERLAND TRINIDAD UNITED ARAB EMI VIETNAM

Lot / Code Information

All lot codes

Other Recalls from Magellan Diagnostics, Inc.

Recall # Classification Product Date
Z-0584-2026 Class II The LeadCare¿ II Blood Lead Test System relies ... Feb 23, 2024
Z-0219-2024 Class II LeadCare II Blood Lead Test Kit-For in vitro di... Sep 19, 2023
Z-1953-2021 Class I LeadCare Plus Blood Lead Test Kit Catalog Numb... May 7, 2021
Z-1952-2021 Class I LeadCare II Blood Lead Test Kit Catalog Number... May 7, 2021
Z-1954-2021 Class I LeadCare Ultra Blood Lead Test Kit Catalog Num... May 7, 2021

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.